Better Choice Company Inc.

    Better Choice Company Inc.

    AAMEX:BTTR
    2.86
    USD
    +0.23
    (+8.72%)
    Better Choice Company Inc.
    AMEX:BTTR
    (NYSE American)

    Recent

    price

    2.86

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2017
    2018
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    - -
    - -
    - -
    - -
    - -
    - -
    0.15
    - -
    0.04
    - -
    123.72
    229.07
    69.45
    81.72
    54.73
    - -
    27.88
    Revenue per Share
    -5,105.87
    -1,988.62
    -11,771.25
    -12.66
    -9.07
    -90.97
    -153.73
    -0.13
    -257.75
    -0.02
    -1,465.97
    -319.69
    5.11
    -58.78
    -32.29
    - -
    -0.13
    Basic EPS, GAAP
    -2,297.62
    -2,217.12
    -2,148.5
    -5.59
    -4.18
    -17.59
    -3.51
    -0.04
    -69.69
    - -
    -167.42
    -41.18
    -17.9
    -30.73
    0.14
    - -
    -3.47
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    7.5
    -29,539.62
    -41,310.87
    -85.07
    -71.94
    -125.42
    -273.85
    - -
    -525.39
    -3.49
    -1,598.21
    -1,401.81
    -391.34
    -446.34
    -455.64
    - -
    -256.3
    Book Value per Share
    -4,993.62
    -6,982.25
    -10,098.75
    -8.16
    -10.53
    -55.95
    -104.31
    - -
    -229.9
    -1.71
    -320.29
    -321.8
    41.78
    17.15
    4.22
    - -
    6.57
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    3
    - -
    3
    - -
    - -
    1
    1
    1
    - -
    1
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    16
    43
    46
    55
    39
    35
    35
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    -439,022.92
    -30,221.34
    - -
    -111,134.11
    - -
    -227.5
    -64.15
    -37.56
    -36.9
    -32.77
    -17.06
    -17.06
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    2
    2
    2
    2
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    -1
    -2
    - -
    -3
    - -
    -184
    -59
    3
    -39
    -23
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1.08
    - -
    - -
    - -
    0.11
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    -1,945,335.42
    -100,533.91
    -188,416.82
    -621,225.05
    - -
    -1,184.19
    -139.32
    7.36
    -71.93
    -59
    -0.48
    -0.48
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    -1
    -1
    - -
    -3
    -7
    -15
    -37
    37
    22
    3
    8
    8
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    17
    25
    9
    12
    - -
    - -
    - -
    LT Debt
    - -
    - -
    - -
    - -
    - -
    -1
    -1
    - -
    -3
    -5
    3
    -28
    58
    22
    3
    9
    9
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -46.18
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -2.76
    - -
    - -
    - -
    4.16
    Return on Capital (%)
    -142.67
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    ST Debt
    2
    2
    2
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    1
    2
    2
    Market Capitalization
    3
    3
    3

    Working Capital

    USD

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    Total Current Assets
    12
    16
    15
    Cash, Cash Equivalents & STI
    3
    5
    3
    Accounts Receivable, Net
    4
    6
    5
    Inventories
    4
    4
    4
    Total Current Liabilities
    9
    7
    7
    Payables & Accruals
    7
    5
    4
    ST Debt
    2
    2
    2
    Deferred Revenue
    - -
    - -
    1

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -233.72%
    190.4%
    Free Cash Flow
    - -
    -925.54%
    -4,591.75%
    Net Income, GAAP
    - -
    -315.13%
    -99.26%
    Sales/Revenue/Turnover
    - -
    32.3%
    -9.37%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    17
    17
    12
    9
    55
    2023
    9
    11
    13
    6
    39
    2024
    8
    9
    11
    7
    35

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -6.07
    -6.54
    -9.81
    -36.42
    -58.78
    2023
    -5.03
    -4.27
    -2.3
    - -
    -32.29
    2024
    -3.6
    2.98
    0.73
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    • Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH' Today, Wednesday, April 30, 2025

    • SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of April 23, 2025

    • Better Choice Company Cancels Previously Announced Stock Dividend

    • Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price

    • Better Choice Company Revises Record Date and Payment Date for Stock Dividend of 0.35 per Share

    • Better Choice Sells Halo's Business in Asia for $8.1 Million in Total Gross Proceeds Including $6.5 Million in Cash Up Front, the Equivalent of $3.34 Per Share

    • Better Choice Company Regains Compliance with NYSE American Continued Listing Standards

    • Better Choice Company Revises Payment Date for Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025

    • Better Choice Company Issues Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025

    • Better Choice Company Chairman Provides Shareholder Update on SRx Health Acquisition and Comments on Recent Debt-to-Equity Transaction

    • Better Choice Company Signs Definitive Agreement for SRx Health Solutions to Convert CAD$4 Million in Debt to Equity

    • BTTR Stock Down 9% Despite Narrowing Q4 Losses and E-Commerce Gains

    • Better Choice Company Inc. (BTTR) Q4 2024 Earnings Call Transcript

    • Better Choice Announces SRx Health's Participation at the 2025 Bloom Burton & Co. Healthcare Investor Conference on May 5th and 6th

    • Better Choice Company Shareholders Overwhelmingly Approve Acquisition of SRx Health Solutions and Related Proposals

    • Better Choice Company Board of Directors Approves Up to 55% Annual Royalty Distribution Plan from its Halo Brand

    • Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence

    • Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET

    • Better Choice Company Appoints Renowned Expert in Rare and Undiagnosed Diseases, Dr. Paldeep S. Atwal, as its United States Special Healthcare Advisor

    • SRx Health Solutions Granted Final Order to Proceed with the Acquisition by Better Choice Company